Microfluidic Electrophoresis for Rapid Plasmid DNA Isoform Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assessing plasmid DNA in samples are slow and unreliable, particularly in determining the proportions of supercoiled, linear, and open circular forms, which are crucial for gene therapy applications, as they degrade during production and storage.
Innovation Solution
A microfluidic electrophoresis method using a detectable label to preferentially label plasmid DNA isoforms, followed by flowing through a polymeric separation medium in a microchannel for separation and detection, allowing for rapid and accurate determination of the proportions of supercoiled, linear, and open circular plasmid DNA.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current methods of assessing plasmid DNA are used, then the assessment can be performed, but the method is slow and unreliable
Solution Approach 1:
The patent replaces conventional mechanical/chemical assessment methods with microfluidic electrophoresis technology. The system uses electric fields to separate plasmid DNA isoforms based on their electrophoretic mobility through a polymeric separation medium, enabling rapid and reliable characterization of supercoiled, linear, and open circular forms simultaneously.
Solution Approach 2:
The patent changes the assessment parameters by using detectable labels that preferentially bind to supercoiled plasmid DNA, allowing differentiation based on electrophoretic mobility and signal intensity. This enables quantitative determination of isoform proportions through controlled variables in the microfluidic system.
2Measurement precision
If conventional plasmid DNA assessment methods are used, then basic characterization is possible, but accuracy in determining isoform proportions is insufficient
Solution Approach 1:
The patent introduces a detectable label as an intermediary substance that preferentially binds to supercoiled plasmid DNA. This label serves as a mediator between the plasmid DNA and the detection system, enabling specific identification and quantification of supercoiled forms while maintaining simplicity in the overall system design.
Solution Approach 2:
The microfluidic system performs multiple functions simultaneously: separation of DNA isoforms, detection of labeled plasmid, quantification of proportions, and characterization of DNA forms. This multi-functionality achieves high measurement precision without proportionally increasing system complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid and reliable assessment of plasmid DNA isoforms, ensuring high accuracy in determining the proportions of supercoiled, linear, and open circular forms, meeting the FDA's 80% supercoiled content requirement for gene therapy applications.
Implementation Method 1
The detectable label is an intercalating agent
Implementation Method 2
flowing the labeled double-stranded plasmid DNA through a polymeric separation medium in a microchannel
Data Source
AI summary
Methods of assessing double-stranded plasmid DNA isoforms to determine a proportion of supercoiled plasmid DNA compared to linear plasmid DNA, and/or open circle plasmid DNA are provided according to aspects of the present disclosure, which include: preferentially labelling double-stranded plasmid DNA; flowing the labeled double-stranded plasmid DNA through a polymeric separation medium in a microchannel into a detection region; detecting the detectable label to determine: a) an amount of time taken by the labeled plasmid DNA isoforms to flow through the polymeric separation medium in the microchannel into the detection region, and/or b) strength of the signal of the detectable label in the detection region; and comparing a) and/or b) to a reference standard thereby determining a proportion of supercoiled plasmid DNA compared to linear plasmid DNA, and/or open circle plasmid DNA in the fluid sample comprising plasmid DNA.